West Pharmaceutical Services (WST) Revenue (2009 - 2026)

West Pharmaceutical Services has disclosed Revenue across 18 years of filings, most recently posting $872.3 million for Q2 2026.

• In Q2 2026, Revenue rose 13.8% year-over-year to $872.3 million; the TTM figure through Jun 2026 stood at $3.3 billion (up 12.38% YoY), while the FY2025 annual figure was $3.1 billion, up 6.25% from the prior year.
• Revenue came in at $872.3 million for Q2 2026 at West Pharmaceutical Services, up from $844.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $872.3 million in Q2 2026 to a low of $686.9 million in Q3 2022.
• Average Revenue over 5 years is $751.2 million, with a median of $747.2 million recorded in 2023.
• Year-over-year, Revenue slipped 6.86% in 2024 and rose 21.05% in 2026.
• Over 5 years, Revenue stood at $708.7 million in 2022, then climbed by 3.29% to $732.0 million in 2023, then rose by 2.3% to $748.8 million in 2024, then increased by 7.51% to $805.0 million in 2025, then grew by 8.36% to $872.3 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $872.3 million in Q2 2026, $844.9 million in Q1 2026, and $805.0 million in Q4 2025.